Head-to-head · Value Score
Vitara RX vs yourEra
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, yourEra a 84. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameyourEra
#25 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 84 — an est. $99/mo first month, with no teaser step-up baked in. yourEra isn't out of it: Shoppers who value seeing the real price upfront and want both molecules plus a longevity menu, and are fine paying a mid-market rate for that transparency.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | yourEra |
|---|---|---|
| Value Score | 91 (A) | 84 (B+) |
| Est. first month | $99/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $299/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | 49 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
yourEra
A transparent, publicly priced GLP-1 program — both molecules at $199/$299 with no hidden quiz-wall — that's honest and mid-market rather than rock-bottom.
Why it's a deal
- Publishes prices openly on the site — $199 sema / $299 tirz — while many compounders hide pricing behind an intake quiz
- Both compounded semaglutide and tirzepatide, plus a broader menu (NAD+, microdosing, optional coaching/nutritionist/lab bundle)
- Markets a 50-state licensed-clinician network; no insurance required and HSA/FSA accepted
The fine print
- Mid-market pricing — $199/$299 sits above the cheapest compounders (~$99–$150), so it's not the value leader
- Compounded only and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound, and availability can tighten as brand shortages resolve
- Injectable only — no FDA-approved brand-name lane and no oral option
- Thin independent footprint; the 50-state and efficacy claims are self-reported
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives ranking, and the same list for the other side is on alternatives to yourEra.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.